Cargando…
Key Chemokine Pathways in Atherosclerosis and Their Therapeutic Potential
The search to improve therapies to prevent or treat cardiovascular diseases (CVDs) rages on, as CVDs remain a leading cause of death worldwide. Here, the main cause of CVDs, atherosclerosis, and its prevention, take center stage. Chemokines and their receptors have long been known to play an importa...
Autores principales: | Márquez, Andrea Bonnin, van der Vorst, Emiel P. C., Maas, Sanne L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432216/ https://www.ncbi.nlm.nih.gov/pubmed/34501271 http://dx.doi.org/10.3390/jcm10173825 |
Ejemplares similares
-
Chemokines and their receptors in Atherosclerosis
por: van der Vorst, Emiel P. C., et al.
Publicado: (2015) -
Inflammatory Chemokines in Atherosclerosis
por: Gencer, Selin, et al.
Publicado: (2021) -
ADAM10 and ADAM17, Major Regulators of Chronic Kidney Disease Induced Atherosclerosis?
por: Maas, Sanne L., et al.
Publicado: (2023) -
High-Density Lipoprotein Modifications: A Pathological Consequence or Cause of Disease Progression?
por: Márquez, Andrea Bonnin, et al.
Publicado: (2020) -
PCSK9 Imperceptibly Affects Chemokine Receptor Expression In Vitro and In Vivo
por: Sundararaman, Sai Sahana, et al.
Publicado: (2021)